Canadian Licensed Producers entering the Australian medical channel face a two-track regulatory process. Health Canada governs the export permit on the Canadian side. The Therapeutic Goods Administration (TGA) and the Office of Drug Control (ODC) jointly govern product quality and import authorisation on the Australian side. Both tracks must be completed for every shipment.
Australia is one of the few markets where product quality standards for cannabis are set by statute. The Therapeutic Goods Order No. 93 (TGO 93) mandates compliance with EU-GMP manufacturing principles and testing by an ISO/IEC 17025-accredited laboratory. Suppliers who cannot demonstrate TGO 93 compliance will not clear the ODC import permit review. What follows is the correct sequence for getting it right the first time.
The Australian regulatory framework for imported cannabis
Australia regulates imported medicinal cannabis through two agencies. The TGA governs product quality and therapeutic use authorisation. The ODC governs narcotic import permits under the Narcotic Drugs Act 1967. A shipment cannot clear Australian customs without both a valid ODC import permit and TGA-standard product documentation.
TGO 93 requires cannabis products to be manufactured under EU-GMP principles and tested by an ISO/IEC 17025-accredited laboratory. Health Canada GMP aligns closely with EU-GMP through the Canada-EU Mutual Recognition Agreement (MRA). That alignment carries real weight with Australian importers. Some buyers will still request a formal EU-GMP certificate rather than relying on the MRA recognition alone, so confirm this requirement before your first shipment.
Australian importers use one of two TGA access pathways: the Special Access Scheme (SAS) Category B for individual patient supply, or the Authorised Prescriber (AP) scheme for high-volume specialists. Neither pathway changes the Canadian LP's export obligations. The distinction matters commercially because AP scheme partners typically move larger and more predictable monthly volumes. Ask prospective partners which pathway they operate under before committing to supply terms.
Health Canada export requirements for the Canadian LP
Every cannabis export from Canada requires authorisation under the Cannabis Act and the Cannabis Regulations. The LP must hold a Standard Cultivation licence with export authorisation endorsed, or a separate processing licence covering the export activity. Micro Cultivation licence holders are not eligible to export.
For each shipment, the LP submits a per-shipment export permit application to Health Canada. The application must include:
- The Australian importer's name, address, and ODC licence number
- The ODC import permit number, or written confirmation the application is in progress
- Product description: dried cannabis flower, strain, lot/batch number, THC and CBD content
- Quantity in grams
- Port of exit and expected shipment date
Health Canada processes export permits within two to four weeks. Submit the application once the Australian partner confirms their ODC application is filed. Both permits can then resolve within the same window. If either permit expires before the shipment departs, a fresh application is required.
The International Narcotics Control Board (INCB) requires that cannabis shipments between signatories carry the import country's authorisation. The ODC import permit fulfils that requirement for Australian shipments. Keep the permit number on file with your export records, as Health Canada may request it during compliance reviews.
TGO 93 compliance: what your batch documentation needs to show
TGO 93 is the most document-intensive part of the Australian export pathway. An ISO/IEC 17025 COA alone is not sufficient. The results must cover the specific analyte panel TGO 93 requires, and each result must fall within the specifications the Australian importer has registered with the TGA.
TGO 93 required testing panel
Australian importers will require COA data covering the following at minimum:
- Total THC and Total CBD (THCA x 0.877 + delta-9-THC)
- Residual solvents, if any post-harvest processing is involved
- Microbial limits: total aerobic count, yeast and mould, Salmonella, E. coli
- Heavy metals: lead, arsenic, cadmium, mercury
- Pesticide residues
- Water activity and moisture content
Confirm that your testing laboratory holds ISO/IEC 17025 accreditation with scope coverage for cannabis matrices. General accreditation without cannabis-specific scope does not satisfy TGO 93.
Stability data requirements
TGO 93 requires that products hold their stated specifications through the declared shelf life. Australian importers typically request ICH Q1A-aligned stability data. Real-time studies at standard storage conditions are the most widely accepted format. Accelerated studies (40 degrees C / 75% RH) can reduce the timeline but may require supplemental real-time data for shelf lives beyond 12 months. LPs without stability data on file should build a three to six month programme before committing to an Australian partner timeline.
A step-by-step export sequence: the Canada-Australia Compliance Path
Six steps, executed in order, cover every requirement for a first shipment from Canada to Australia.
- Qualify the Australian partner. Confirm they hold an ODC import licence, an active TGA access pathway (SAS-B or AP), and product approval for your specific format. Request their TGA registration or product details number.
- Confirm TGO 93 documentation readiness. Before setting a shipment date, verify the batch COA covers the full TGO 93 panel from a lab with the correct accreditation scope. Confirm stability data is on file if required.
- Run parallel permit applications. The importer files for the ODC import permit. The LP files the Health Canada export permit application simultaneously, referencing the importer's ODC application number. Both typically clear within two to four weeks.
- Assemble the shipment documentation package. Each shipment requires: the Health Canada export permit, the ODC import permit, the batch COA, a Certificate of Origin, a commercial invoice with lot number and HS tariff code, and the packing manifest. Incomplete documentation is the primary cause of Australian customs holds.
- Ship under temperature-controlled conditions. Cannabis flower is sensitive to temperature and humidity excursions during transit. Australian importers and TGA auditors expect chain-of-custody records confirming validated storage conditions throughout. Use a GDP-compliant cold-chain carrier and retain all temperature logs.
- Reconcile on arrival. The importer must notify the ODC of each consignment received. Confirm the received quantity against the permit and retain the importer's reconciliation record alongside your own export file. Health Canada may request it during compliance reviews.
AlphaLeaf is a Montreal-based Health Canada Licensed Producer specialising in indoor-grown, hand-trimmed cannabis flower. We carry export authorisation under the Cannabis Act, ISO/IEC 17025-certified batch testing, and full traceability from cultivation through to shipment. For importers and pharmacy distributors navigating TGO 93 requirements, our compliance documentation and Australian channel experience make supply coordination straightforward. Contact our team to discuss your requirements.
Related reading: EU-GMP Certification for Canadian Cannabis LPs, How to Read a Cannabis COA, and Cannabis Stability and Shelf-Life Testing.
Frequently Asked Questions
Can Canadian Licensed Producers export cannabis to Australia?
Yes. Canadian LPs with a valid export authorisation under the Cannabis Act can export dried cannabis flower to Australia. The product must meet TGO 93 quality standards, and the Australian importer must hold a valid ODC import permit and TGA access pathway authorisation.
Does Canadian GMP satisfy TGO 93 manufacturing requirements?
Health Canada GMP is closely aligned with EU-GMP principles, which TGO 93 references as its manufacturing benchmark. Some Australian importers request a formal EU-GMP certificate rather than relying on the Canada-EU Mutual Recognition Agreement alone. Confirm documentation requirements with your importer before finalising a shipment date.
What is the ODC import permit and who applies for it?
The ODC import permit is issued by the Office of Drug Control under the Narcotic Drugs Act 1967. The Australian importer applies, not the Canadian exporter. The permit covers a specific product, quantity, supplier, and port of entry. The LP must provide the batch COA and Health Canada export permit number to support the application.
How long does the Australian import permit process take?
ODC import permit processing takes two to four weeks once the application is complete. The Health Canada export permit runs on a similar timeline. Running both in parallel keeps total lead time to six to ten weeks for a first shipment.
What shelf-life data does Australia require for cannabis imports?
TGO 93 requires products to maintain their stated specifications throughout the declared shelf life. Australian importers typically request ICH Q1A-aligned stability data showing potency and microbial limits hold at end of shelf life. LPs without stability data on file should plan for a three to six month stability study before targeting the Australian channel.
